Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    Downsample data for MiSeq Reporter

    As the amount of raw data generated by the MiSeq continues to grow we are starting to run into situations where even this "Benchtop" sequencer produces more data than is needed (or wanted) for a de novo genome assembly of things like bacteria and fungi, even with the Micro and Nano options. If I am going to do a de novo assembly offline I can simply downsample the data myself. But what if I want to use the built in MiSeq Reporter de novo assembly pipeline? Is there any way to configure it to only use a portion of the raw data for assembly?
  • kcchan
    Senior Member
    • Jul 2012
    • 186

    #2
    Currently the default assembly pipeline in the MiSeq can only handle 550Mb of sequence. You can decrease it by playing with the config files in MSR. You can read the MSR Theory of Operations document available on the Illumina website.

    However, it seems strange to be throwing perfectly good reads away. Have you considered multiplexing more samples into the run so you generate more useful data?

    Comment

    • kmcarr
      Senior Member
      • May 2008
      • 1181

      #3
      Originally posted by kcchan View Post
      Currently the default assembly pipeline in the MiSeq can only handle 550Mb of sequence. You can decrease it by playing with the config files in MSR. You can read the MSR Theory of Operations document available on the Illumina website.

      However, it seems strange to be throwing perfectly good reads away. Have you considered multiplexing more samples into the run so you generate more useful data?
      Thanks for the info. Regarding multiplexing, yes that would be ideal, but as a core we have to take what researchers send us. Sometimes all they have is one sample.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        This could be a good opportunity to spread some goodwill around. You can donate the spare capacity to deserving labs on campus, who are truly unable to afford the cost.

        Comment

        • genbio64
          Member
          • Dec 2009
          • 42

          #5
          Is this feature new in the last software update? Illumina had told us there was virtually no flexibility when it came to the downstream pipelines through MSR.

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            Originally posted by genbio64 View Post
            Is this feature new in the last software update? Illumina had told us there was virtually no flexibility when it came to the downstream pipelines through MSR.
            MiSeq reporter v.2.1.43 was released just last week so it may be a new feature or an undocumented one Illumina wants people to generally stay away from.

            Comment

            • kcchan
              Senior Member
              • Jul 2012
              • 186

              #7
              It's definitely good practice not to mess with the default analysis settings. Changing the settings will affect all future analysis, so know what you're doing before playing with the config files and revert them back if the next person needs the default settings. Most of the time I find it easier to do the downstream analysis myself and not on the instrument.

              Comment

              • mcnelson.phd
                Senior Member
                • Jul 2011
                • 162

                #8
                Can I ask why you would even want Reporter to do de novo assembly? Unless things have changed with the newest version, Reporter (and Basespace) does no trimming or quality discrimination during its assembly, and I can't remember if it properly handles paired data. Every assembly done using Reporter that I've seen looks worthless compared to one's that I've done using Velvet on my own.

                I guess if people are just sending you samples to sequence and intend to assemble it themselves, and you give them the assembly that Reporter spits out as a "bonus" along with the raw data then there's no real harm. But I think relying solely on an assembly done using Reporter or Basespace is pretty sloppy.

                My opinion only of course though.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  Today, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Today, 11:10 AM
                0 responses
                8 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                30 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                39 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-08-2026, 10:08 AM
                0 responses
                25 views
                0 reactions
                Last Post SEQadmin2  
                Working...